Skip to main content
NCBI home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1984 Jan 7;288(6410):9–11. doi: 10.1136/bmj.288.6410.9

Penile erection: possible role for vasoactive intestinal polypeptide as a neurotransmitter.

B Ottesen, G Wagner, R Virag, J Fahrenkrug
PMCID: PMC1444192  PMID: 6140066

Abstract

Concentrations of vasoactive intestinal polypeptide were measured in blood drawn from the cavernous spaces of corpus cavernosum of the human penis during tumescence and erection, and the effect of injecting the polypeptide into the cavernous spaces was studied. A significant release of the polypeptide was shown during tumescence and erection. Injection of exogenous vasoactive intestinal polypeptide induced erection. These findings support the concept of vasoactive intestinal polypeptide as a neurotransmitter in penile erection and suggest that it might have a clinical use in patients suffering from erectile dysfunction.

Full text

PDF
9

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brindley G. S. Cavernosal alpha-blockade: a new technique for investigating and treating erectile impotence. Br J Psychiatry. 1983 Oct;143:332–337. doi: 10.1192/bjp.143.4.332. [DOI] [PubMed] [Google Scholar]
  2. Fahrenkrug J., Schaffalitzky de Muckadell O. V. Radioimmunoassay of vasoactive intestinal polypeptide (VIP) in plasma. J Lab Clin Med. 1977 Jun;89(6):1379–1388. [PubMed] [Google Scholar]
  3. Fahrenkrug J. Vasoactive intestinal polypeptide: measurement, distribution and putative neurotransmitter function. Digestion. 1979;19(3):149–169. doi: 10.1159/000198339. [DOI] [PubMed] [Google Scholar]
  4. Klinge E., Sjöstrand N. O. Comparative study of some isolated mammalian smooth muscle effectors of penile erection. Acta Physiol Scand. 1977 Jul;100(3):354–367. doi: 10.1111/j.1748-1716.1977.tb05961.x. [DOI] [PubMed] [Google Scholar]
  5. Mutt V., Said S. I. Structure of the porcine vasoactive intestinal octacosapeptide. The amino-acid sequence. Use of kallikrein in its determination. Eur J Biochem. 1974 Mar 1;42(2):581–589. doi: 10.1111/j.1432-1033.1974.tb03373.x. [DOI] [PubMed] [Google Scholar]
  6. Ottesen B. Vasoactive intestinal polypeptide as a neurotransmitter in the female genital tract. Am J Obstet Gynecol. 1983 Sep 15;147(2):208–224. doi: 10.1016/0002-9378(83)90117-5. [DOI] [PubMed] [Google Scholar]
  7. Polak J. M., Gu J., Mina S., Bloom S. R. Vipergic nerves in the penis. Lancet. 1981 Aug 1;2(8240):217–219. doi: 10.1016/s0140-6736(81)90471-2. [DOI] [PubMed] [Google Scholar]
  8. Sjöstrand N. O., Klinge E. Principal mechanisms controlling penile retraction and protrusion in rabbits. Acta Physiol Scand. 1979 Jun;106(2):199–214. doi: 10.1111/j.1748-1716.1979.tb06390.x. [DOI] [PubMed] [Google Scholar]
  9. Willis E. A., Ottesen B., Wagner G., Sundler F., Fahrenkrug J. Vasoactive intestinal polypeptide (VIP) as a putative neurotransmitter in penile erection. Life Sci. 1983 Jul 25;33(4):383–391. doi: 10.1016/s0024-3205(83)80013-7. [DOI] [PubMed] [Google Scholar]
  10. Willis E., Ottesen B., Wagner G., Sundler F., Fahrenkrug J. Vasoactive intestinal polypeptide (VIP) as a possible neurotransmitter involved in penile erection. Acta Physiol Scand. 1981 Dec;113(4):545–547. doi: 10.1111/j.1748-1716.1981.tb06936.x. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES